1. トップ >
  2. Medical Affairs Website >
  3. その他領域Publication一覧

その他領域Publication一覧

　毎月更新予定
（最終更新：2024/4）

こちらには弊社社員が著者に含まれる論文や、弊社から資金提供・原薬提供などを行った研究論文を掲載しています。

その他領域

  • Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of the Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2019-2020: General view of the pathogens' antibacterial susceptibility.

    I.Tokimatsu et al. J Infect Chemother. 2023 Aug;29(8):731-743.

  • Association between fluid infusions and the recovery from acute kidney injury in patients administered liposomal amphotericin B: a nationwide observational study.

    M.Tashiro et al. Ren Fail. 2022 Dec;44(1):282-292.

  • Association between potassium supplementation and the occurrence of acute kidney injury in patients with hypokalemia administered liposomal amphotericin B: a nationwide observational study.

    Y.Ota et al. BMC Nephrol. 2021 Jun 30;22(1):240.

  • Efficacy of early administration of liposomal amphotericin B in patients with septic shock: A nationwide observational study.

    M.Tashiro et al. J Infect Chemother. 2021 Oct;27(10):1471-1476.

  • Correction to: The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study.

    Y.Obata et al. Clin Exp Nephrol. 2021 Mar;25(3):288.

  • The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study.

    Y.Obata et al. Clin Exp Nephrol. 2021 Mar;25(3):279-287.

  • Impact of chronic constipation on health-related quality of life and work productivity in Japan.　

    T.Tomita et al. J Gastroenterol Hepatol. 2021 Jun;36(6):1529-1537.

  • Factor analysis of acute kidney injury in patients administered liposomal amphotericin B in a real-world clinical setting in Japan.

    T.Takazono et al. Sci Rep. 2020 Sep 14;10(1):15033.

  • Antimicrobial susceptibility surveillance of bacterial isolates recovered in Japan from odontogenic infections in 2013.

    A.Kaneko et al. J Infect Chemother. 2020 Sep;26(9):882-889.

  • Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of japanese society of chemotherapy, the japanese association for infectious diseases, and the japanese society for clinical microbiology in 2016: General view of the pathogens' antibacterial susceptibility.

    K.Yanagihara et al. J Infect Chemother. 2020 Sep;26(9):873-881.

  • Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014: General view of the pathogens' antibacterial susceptibility.

    K.Yanagihara et al. J Infect Chemother. 2019 Sep;25(9):657-668.

  • Plasma lyso-Gb3: a biomarker for monitoring fabry patients during enzyme replacement therapy.

    H.Sakuraba et al. Clinical and Experimental Nephrology. 2018; 22:843–849

  • Accuracy of non-invasive scoring systems for diagnosing non-alcoholic steatohepatitis-related fibrosis: Multicenter validation study.

    Y.Itoh et al. Hepatology Research. 2018; 48: 1099–1107